A recent study conducted by researchers at Washington University School of Medicine in St. Louis has found a link between poor sleep quality and an increased risk of developing Alzheimer’s disease. As Alzheimer’s patients have more orexin-producing neurons in their brains, which disrupts sleep patterns, the FDA-approved insomnia pill known as suvorexant, which blocks orexin, may actually increase the likelihood of developing the disease. The study underscores the importance of good sleep for brain health, particularly for older adults, and urges caution in the use of sleep aids. Additionally, the findings point to potential therapeutic targets for Alzheimer’s treatment that focus on orexin regulation.
Today: December 10, 2023